Only one currently authorized antibody treatment retains its activity against all omicron subvariants, according to new research by scientists at Columbia University and the University of Hong Kong. The study also shows that the effectiveness of mRNA vaccines is reduced against all three subvariants of omicron. The findings were published in Nature(link is external and opens in...